The Company is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops, manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products within domestic market and to overseas markets. The Company was founded on April 22, 2011. and its shares are listed on Korea Stock Exchange on November 10, 2016.
Headquarters
300 Songdo Bio Way (Daero), Yeonsu-Gu
Incheon; Incheon;
Contact Details: Purchase the Samsung Biologics Co., Ltd. report to view the information.
Website: http://www.samsungbiologics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service